Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Vaccine for Influenza market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Vaccine for Influenza production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Vaccine for Influenza by regions (countries) and by Application.
The global Vaccine for Influenza market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Vaccine for Influenza market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Vaccine for Influenza markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Vaccine for Influenza market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Vaccine for Influenza market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Vaccine for Influenza market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Vaccine for Influenza market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Vaccine for Influenza market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Vaccine for Influenza market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Vaccine for Influenza market by each application segment for the same period.
This report includes the following manufacturers:
Sanofi
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Market Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Research Methodology
To compile the detailed study of the global Vaccine for Influenza market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Vaccine for Influenza market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Vaccine for Influenza market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
The global Vaccine for Influenza market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Vaccine for Influenza production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Vaccine for Influenza by regions (countries) and by Application.
The global Vaccine for Influenza market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Vaccine for Influenza market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Vaccine for Influenza markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Vaccine for Influenza market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Vaccine for Influenza market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Vaccine for Influenza market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Vaccine for Influenza market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Vaccine for Influenza market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Vaccine for Influenza market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Vaccine for Influenza market by each application segment for the same period.
This report includes the following manufacturers:
Sanofi
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Market Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Research Methodology
To compile the detailed study of the global Vaccine for Influenza market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Vaccine for Influenza market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Vaccine for Influenza market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Vaccine for Influenza Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Segment by Application
1.3.1 Global Vaccine for Influenza Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vaccine for Influenza Market Size (2016-2027)
2.1.1 Global Vaccine for Influenza Revenue (2016-2027)
2.1.2 Global Vaccine for Influenza Sales (2016-2027)
2.2 Global Vaccine for Influenza Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Vaccine for Influenza Sales by Regions (2016-2021)
2.2.2 Global Vaccine for Influenza Revenue by Regions (2016-2021)
2.3 Global Vaccine for Influenza Market Size Forecast by Region
2.3.1 Global Vaccine for Influenza Sales Forecast by Region (2022-2027)
2.3.2 Global Vaccine for Influenza Revenue Forecast by Region (2022-2027)
2.4 Global Top Vaccine for Influenza Regions (Countries) Ranking by Market Size
2.5 Vaccine for Influenza Industry Trends
2.5.1 Vaccine for Influenza Market Trends
2.5.2 Vaccine for Influenza Market Drivers
2.5.3 Vaccine for Influenza Market Challenges
2.5.4 Vaccine for Influenza Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Vaccine for Influenza Manufacturers by Sales (2016-2021)
3.1.1 Global Vaccine for Influenza Sales by Manufacturers (2016-2021)
3.1.2 Global Vaccine for Influenza Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Vaccine for Influenza Sales in 2020
3.2 Global Top Manufacturers Vaccine for Influenza by Revenue
3.2.1 Global Vaccine for Influenza Revenue by Manufacturers (2016-2021)
3.2.2 Top Vaccine for Influenza Manufacturers Covered: Ranking by Revenue
3.2.3 Global Vaccine for Influenza Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Vaccine for Influenza Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2020)
3.4 Global Vaccine for Influenza Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vaccine for Influenza Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vaccine for Influenza Market
3.7 Key Manufacturers Vaccine for Influenza Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vaccine for Influenza Market Size by Type
4.1 Global Vaccine for Influenza Historic Market Review by Type (2016-2021)
4.1.1 Global Vaccine for Influenza Sales Market Share by Type (2016-2021)
4.1.2 Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)
4.1.3 Vaccine for Influenza Price by Type (2016-2021)
4.2 Global Vaccine for Influenza Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Vaccine for Influenza Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccine for Influenza Revenue Forecast by Type (2022-2027)
4.2.3 Vaccine for Influenza Price Forecast by Type (2022-2027)
5 Global Vaccine for Influenza Market Size by Application
5.1 Global Vaccine for Influenza Historic Market Review by Application (2016-2021)
5.1.1 Global Vaccine for Influenza Sales Market Share by Application (2016-2021)
5.1.2 Global Vaccine for Influenza Revenue Market Share by Application (2016-2021)
5.1.3 Vaccine for Influenza Price by Application (2016-2021)
5.2 Global Vaccine for Influenza Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Vaccine for Influenza Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccine for Influenza Revenue Forecast by Application (2022-2027)
5.2.3 Vaccine for Influenza Price Forecast by Application (2022-2027)
6 North America
6.1 North America Vaccine for Influenza Sales Breakdown by Company
6.1.1 North America Vaccine for Influenza Sales by Company (2016-2027)
6.1.2 North America Vaccine for Influenza Revenue by Company (2016-2027)
6.2 North America Vaccine for Influenza Market Size by Type (2016-2027)
6.2.1 North America Vaccine for Influenza Sales by Type (2016-2027)
6.2.2 North America Vaccine for Influenza Revenue by Type (2016-2027)
6.3 North America Vaccine for Influenza Market Size by Application (2016-2027)
6.3.1 North America Vaccine for Influenza Sales by Application (2016-2027)
6.3.2 North America Vaccine for Influenza Revenue by Application (2016-2027)
6.4 North America Vaccine for Influenza Market Size by Country
6.4.1 North America Vaccine for Influenza Sales by Country (2016-2027)
6.4.2 North America Vaccine for Influenza Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Vaccine for Influenza Sales Breakdown by Company
7.1.1 Europe Vaccine for Influenza Sales by Company (2016-2027)
7.1.2 Europe Vaccine for Influenza Revenue by Company (2016-2027)
7.2 Europe Vaccine for Influenza Market Size by Type (2016-2027)
7.2.1 Europe Vaccine for Influenza Sales by Type (2016-2027)
7.2.2 Europe Vaccine for Influenza Revenue by Type (2016-2027)
7.3 Europe Vaccine for Influenza Market Size by Application (2016-2027)
7.3.1 Europe Vaccine for Influenza Sales by Application (2016-2027)
7.3.2 Europe Vaccine for Influenza Revenue by Application (2016-2027)
7.4 Europe Vaccine for Influenza Market Size by Country
7.4.1 Europe Vaccine for Influenza Sales by Country (2016-2027)
7.4.2 Europe Vaccine for Influenza Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccine for Influenza Sales Breakdown by Company
8.1.1 Asia Pacific Vaccine for Influenza Sales by Company (2016-2027)
8.1.2 Asia Pacific Vaccine for Influenza Revenue by Company (2016-2027)
8.2 Asia Pacific Vaccine for Influenza Market Size by Type (2016-2027)
8.2.1 Asia Pacific Vaccine for Influenza Sales by Type (2016-2027)
8.2.2 Asia Pacific Vaccine for Influenza Revenue by Type (2016-2027)
8.3 Asia Pacific Vaccine for Influenza Market Size by Application (2016-2027)
8.3.1 Asia Pacific Vaccine for Influenza Sales by Application (2016-2027)
8.3.2 Asia Pacific Vaccine for Influenza Revenue by Application (2016-2027)
8.4 Asia Pacific Vaccine for Influenza Market Size by Regions
8.4.1 Asia Pacific Vaccine for Influenza Sales by Regions
8.4.2 Asia Pacific Vaccine for Influenza Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Vaccine for Influenza Sales Breakdown by Company
9.1.1 Latin America Vaccine for Influenza Sales by Company (2016-2027)
9.1.2 Latin America Vaccine for Influenza Revenue by Company (2016-2027)
9.2 Latin America Vaccine for Influenza Market Size by Type (2016-2027)
9.2.1 Latin America Vaccine for Influenza Sales by Type (2016-2027)
9.2.2 Latin America Vaccine for Influenza Revenue by Type (2016-2027)
9.3 Latin America Vaccine for Influenza Market Size by Application (2016-2027)
9.3.1 Latin America Vaccine for Influenza Sales by Application (2016-2027)
9.3.2 Latin America Vaccine for Influenza Revenue by Application (2016-2027)
9.4 Latin America Vaccine for Influenza Market Size by Country
9.4.1 Latin America Vaccine for Influenza Sales by Country (2016-2027)
9.4.2 Latin America Vaccine for Influenza Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccine for Influenza Sales Breakdown by Company
10.1.1 Middle East and Africa Vaccine for Influenza Sales by Company (2016-2027)
10.1.2 Middle East and Africa Vaccine for Influenza Revenue by Company (2016-2027)
10.2 Middle East and Africa Vaccine for Influenza Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Vaccine for Influenza Sales by Type (2016-2027)
10.2.2 Middle East and Africa Vaccine for Influenza Revenue by Type (2016-2027)
10.3 Middle East and Africa Vaccine for Influenza Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Vaccine for Influenza Sales by Application (2016-2027)
10.3.2 Middle East and Africa Vaccine for Influenza Revenue by Application (2016-2027)
10.4 Middle East and Africa Vaccine for Influenza Market Size by Country
10.4.1 Middle East and Africa Vaccine for Influenza Sales by Country (2016-2027)
10.4.2 Middle East and Africa Vaccine for Influenza Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Sanofi Vaccine for Influenza Products and Services
11.1.5 Sanofi Vaccine for Influenza SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 CSL Vaccine for Influenza Products and Services
11.2.5 CSL Vaccine for Influenza SWOT Analysis
11.2.6 CSL Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 GSK Vaccine for Influenza Products and Services
11.3.5 GSK Vaccine for Influenza SWOT Analysis
11.3.6 GSK Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Mylan Vaccine for Influenza Products and Services
11.4.5 Mylan Vaccine for Influenza SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 Hulan Bio
11.5.1 Hulan Bio Corporation Information
11.5.2 Hulan Bio Overview
11.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Hulan Bio Vaccine for Influenza Products and Services
11.5.5 Hulan Bio Vaccine for Influenza SWOT Analysis
11.5.6 Hulan Bio Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Overview
11.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 AstraZeneca Vaccine for Influenza Products and Services
11.6.5 AstraZeneca Vaccine for Influenza SWOT Analysis
11.6.6 AstraZeneca Recent Developments
11.7 CCBIO
11.7.1 CCBIO Corporation Information
11.7.2 CCBIO Overview
11.7.3 CCBIO Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 CCBIO Vaccine for Influenza Products and Services
11.7.5 CCBIO Vaccine for Influenza SWOT Analysis
11.7.6 CCBIO Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vaccine for Influenza Value Chain Analysis
12.2 Vaccine for Influenza Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine for Influenza Production Mode & Process
12.4 Vaccine for Influenza Sales and Marketing
12.4.1 Vaccine for Influenza Sales Channels
12.4.2 Vaccine for Influenza Distributors
12.5 Vaccine for Influenza Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Vaccine for Influenza Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Segment by Application
1.3.1 Global Vaccine for Influenza Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vaccine for Influenza Market Size (2016-2027)
2.1.1 Global Vaccine for Influenza Revenue (2016-2027)
2.1.2 Global Vaccine for Influenza Sales (2016-2027)
2.2 Global Vaccine for Influenza Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Vaccine for Influenza Sales by Regions (2016-2021)
2.2.2 Global Vaccine for Influenza Revenue by Regions (2016-2021)
2.3 Global Vaccine for Influenza Market Size Forecast by Region
2.3.1 Global Vaccine for Influenza Sales Forecast by Region (2022-2027)
2.3.2 Global Vaccine for Influenza Revenue Forecast by Region (2022-2027)
2.4 Global Top Vaccine for Influenza Regions (Countries) Ranking by Market Size
2.5 Vaccine for Influenza Industry Trends
2.5.1 Vaccine for Influenza Market Trends
2.5.2 Vaccine for Influenza Market Drivers
2.5.3 Vaccine for Influenza Market Challenges
2.5.4 Vaccine for Influenza Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Vaccine for Influenza Manufacturers by Sales (2016-2021)
3.1.1 Global Vaccine for Influenza Sales by Manufacturers (2016-2021)
3.1.2 Global Vaccine for Influenza Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Vaccine for Influenza Sales in 2020
3.2 Global Top Manufacturers Vaccine for Influenza by Revenue
3.2.1 Global Vaccine for Influenza Revenue by Manufacturers (2016-2021)
3.2.2 Top Vaccine for Influenza Manufacturers Covered: Ranking by Revenue
3.2.3 Global Vaccine for Influenza Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Vaccine for Influenza Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2020)
3.4 Global Vaccine for Influenza Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vaccine for Influenza Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vaccine for Influenza Market
3.7 Key Manufacturers Vaccine for Influenza Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vaccine for Influenza Market Size by Type
4.1 Global Vaccine for Influenza Historic Market Review by Type (2016-2021)
4.1.1 Global Vaccine for Influenza Sales Market Share by Type (2016-2021)
4.1.2 Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)
4.1.3 Vaccine for Influenza Price by Type (2016-2021)
4.2 Global Vaccine for Influenza Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Vaccine for Influenza Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccine for Influenza Revenue Forecast by Type (2022-2027)
4.2.3 Vaccine for Influenza Price Forecast by Type (2022-2027)
5 Global Vaccine for Influenza Market Size by Application
5.1 Global Vaccine for Influenza Historic Market Review by Application (2016-2021)
5.1.1 Global Vaccine for Influenza Sales Market Share by Application (2016-2021)
5.1.2 Global Vaccine for Influenza Revenue Market Share by Application (2016-2021)
5.1.3 Vaccine for Influenza Price by Application (2016-2021)
5.2 Global Vaccine for Influenza Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Vaccine for Influenza Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccine for Influenza Revenue Forecast by Application (2022-2027)
5.2.3 Vaccine for Influenza Price Forecast by Application (2022-2027)
6 North America
6.1 North America Vaccine for Influenza Sales Breakdown by Company
6.1.1 North America Vaccine for Influenza Sales by Company (2016-2027)
6.1.2 North America Vaccine for Influenza Revenue by Company (2016-2027)
6.2 North America Vaccine for Influenza Market Size by Type (2016-2027)
6.2.1 North America Vaccine for Influenza Sales by Type (2016-2027)
6.2.2 North America Vaccine for Influenza Revenue by Type (2016-2027)
6.3 North America Vaccine for Influenza Market Size by Application (2016-2027)
6.3.1 North America Vaccine for Influenza Sales by Application (2016-2027)
6.3.2 North America Vaccine for Influenza Revenue by Application (2016-2027)
6.4 North America Vaccine for Influenza Market Size by Country
6.4.1 North America Vaccine for Influenza Sales by Country (2016-2027)
6.4.2 North America Vaccine for Influenza Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Vaccine for Influenza Sales Breakdown by Company
7.1.1 Europe Vaccine for Influenza Sales by Company (2016-2027)
7.1.2 Europe Vaccine for Influenza Revenue by Company (2016-2027)
7.2 Europe Vaccine for Influenza Market Size by Type (2016-2027)
7.2.1 Europe Vaccine for Influenza Sales by Type (2016-2027)
7.2.2 Europe Vaccine for Influenza Revenue by Type (2016-2027)
7.3 Europe Vaccine for Influenza Market Size by Application (2016-2027)
7.3.1 Europe Vaccine for Influenza Sales by Application (2016-2027)
7.3.2 Europe Vaccine for Influenza Revenue by Application (2016-2027)
7.4 Europe Vaccine for Influenza Market Size by Country
7.4.1 Europe Vaccine for Influenza Sales by Country (2016-2027)
7.4.2 Europe Vaccine for Influenza Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccine for Influenza Sales Breakdown by Company
8.1.1 Asia Pacific Vaccine for Influenza Sales by Company (2016-2027)
8.1.2 Asia Pacific Vaccine for Influenza Revenue by Company (2016-2027)
8.2 Asia Pacific Vaccine for Influenza Market Size by Type (2016-2027)
8.2.1 Asia Pacific Vaccine for Influenza Sales by Type (2016-2027)
8.2.2 Asia Pacific Vaccine for Influenza Revenue by Type (2016-2027)
8.3 Asia Pacific Vaccine for Influenza Market Size by Application (2016-2027)
8.3.1 Asia Pacific Vaccine for Influenza Sales by Application (2016-2027)
8.3.2 Asia Pacific Vaccine for Influenza Revenue by Application (2016-2027)
8.4 Asia Pacific Vaccine for Influenza Market Size by Regions
8.4.1 Asia Pacific Vaccine for Influenza Sales by Regions
8.4.2 Asia Pacific Vaccine for Influenza Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Vaccine for Influenza Sales Breakdown by Company
9.1.1 Latin America Vaccine for Influenza Sales by Company (2016-2027)
9.1.2 Latin America Vaccine for Influenza Revenue by Company (2016-2027)
9.2 Latin America Vaccine for Influenza Market Size by Type (2016-2027)
9.2.1 Latin America Vaccine for Influenza Sales by Type (2016-2027)
9.2.2 Latin America Vaccine for Influenza Revenue by Type (2016-2027)
9.3 Latin America Vaccine for Influenza Market Size by Application (2016-2027)
9.3.1 Latin America Vaccine for Influenza Sales by Application (2016-2027)
9.3.2 Latin America Vaccine for Influenza Revenue by Application (2016-2027)
9.4 Latin America Vaccine for Influenza Market Size by Country
9.4.1 Latin America Vaccine for Influenza Sales by Country (2016-2027)
9.4.2 Latin America Vaccine for Influenza Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccine for Influenza Sales Breakdown by Company
10.1.1 Middle East and Africa Vaccine for Influenza Sales by Company (2016-2027)
10.1.2 Middle East and Africa Vaccine for Influenza Revenue by Company (2016-2027)
10.2 Middle East and Africa Vaccine for Influenza Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Vaccine for Influenza Sales by Type (2016-2027)
10.2.2 Middle East and Africa Vaccine for Influenza Revenue by Type (2016-2027)
10.3 Middle East and Africa Vaccine for Influenza Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Vaccine for Influenza Sales by Application (2016-2027)
10.3.2 Middle East and Africa Vaccine for Influenza Revenue by Application (2016-2027)
10.4 Middle East and Africa Vaccine for Influenza Market Size by Country
10.4.1 Middle East and Africa Vaccine for Influenza Sales by Country (2016-2027)
10.4.2 Middle East and Africa Vaccine for Influenza Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Sanofi Vaccine for Influenza Products and Services
11.1.5 Sanofi Vaccine for Influenza SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 CSL Vaccine for Influenza Products and Services
11.2.5 CSL Vaccine for Influenza SWOT Analysis
11.2.6 CSL Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 GSK Vaccine for Influenza Products and Services
11.3.5 GSK Vaccine for Influenza SWOT Analysis
11.3.6 GSK Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Mylan Vaccine for Influenza Products and Services
11.4.5 Mylan Vaccine for Influenza SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 Hulan Bio
11.5.1 Hulan Bio Corporation Information
11.5.2 Hulan Bio Overview
11.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Hulan Bio Vaccine for Influenza Products and Services
11.5.5 Hulan Bio Vaccine for Influenza SWOT Analysis
11.5.6 Hulan Bio Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Overview
11.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 AstraZeneca Vaccine for Influenza Products and Services
11.6.5 AstraZeneca Vaccine for Influenza SWOT Analysis
11.6.6 AstraZeneca Recent Developments
11.7 CCBIO
11.7.1 CCBIO Corporation Information
11.7.2 CCBIO Overview
11.7.3 CCBIO Vaccine for Influenza Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 CCBIO Vaccine for Influenza Products and Services
11.7.5 CCBIO Vaccine for Influenza SWOT Analysis
11.7.6 CCBIO Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vaccine for Influenza Value Chain Analysis
12.2 Vaccine for Influenza Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine for Influenza Production Mode & Process
12.4 Vaccine for Influenza Sales and Marketing
12.4.1 Vaccine for Influenza Sales Channels
12.4.2 Vaccine for Influenza Distributors
12.5 Vaccine for Influenza Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
